Differential Regulation of Behavioral Tolerance to WIN55,212-2 by GASP1

Neuropsychopharmacology

Volumn 35, Issue 6, 2010, Pages 1363-1373

  Martini, Lene ^a   Thompson, Dawn ^a   Kharazia, Viktor ^a   Whistler, Jennifer L ^a  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

Author keywords

CB1 receptor; Downregulation; GASP; Tolerance; Trafficking; WIN55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR ASSOCIATED SORTING PROTEIN1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG TOLERABILITY; HYPOTHERMIA; LOCOMOTION; MOTOR COORDINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; WILD TYPE;

ANALGESICS; ANIMALS; BENZOXAZINES; CANNABINOIDS; CARRIER PROTEINS; DOWN-REGULATION; DRUG TOLERANCE; ENDOCYTOSIS; MALE; MICE; MICE, KNOCKOUT; MORPHOLINES; MOTOR ACTIVITY; NAPHTHALENES; PAIN; PROTEIN TRANSPORT; RECEPTOR, CANNABINOID, CB1;

EID: 77951116102     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.6     Document Type: Article

References (47)

1. Barna I, Till I, Haller J (2009). Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: compound-specific and area-specific distribution within the brain. Eur Neuropsy-chopharmacol 19: 533-541.
2. Bartlett SE, Enquist J, Hopf FW, Lee JH, Gladher F, Kharazia V et al. (2005). Dopamine responsiveness is regulated by targeted sorting of D2 receptors. Proc Natl Acad Sci USA 102: 11521-11526.
3. Bass CE, Martin BR (2000). Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice. Drug Alcohol Depend 60: 113-119.
4. Boeuf J, Trigo JM, Moreau PH, Lecourtier L, Vogel E, Cassel JC et al. (2009). Attenuated behavioural responses to acute and chronic cocaine in GASP-1-deficient mice. Eur J Neurosci 30: 860-868.
5. Boulant JA (1981). Hypothalamic mechanisms in thermoregula-tion. Fed Proc 40: 2843-2850.
6. Breivogel CS, Sim LJ, Childers SR (1997). Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J Phar-macol Exp Ther 282: 1632-1642.
7. De Vry J, Jentzsch KR, Kuhl E, Eckel G (2004). Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development. Behav Pharmacol 15: 1-12.
8. Dewey WL (1986). Cannabinoid pharmacology. Pharmacol Rev 38: 151-178.
9. Enquist J, Skroder C, Whistler JL, Leeb-Lundberg LM (2007). Kinins promote B2 receptor endocytosis and delay constitutive B1 receptor endocytosis. Mol Pharmacol 71: 494-507.
10. Fan F, Tao Q, Abood M, Martin BR (1996). Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55 940 on adenylyl cyclase in the cerebellum of CP 55940-tolerant mice. Brain Res 706: 13-20.
11. Gonzalez S, Cebeira M, Fernandez-Ruiz J (2005). Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacol Biochem Behav 81: 300-318.
12. Griffin G, Atkinson PJ, Showalter VM, Martin BR, Abood ME (1998). Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes. J Pharmacol Exp Ther 285: 553-560.
13. Hanyaloglu AC, von Zastrow M (2008). Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 48: 537-568.
14. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991). Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradio-graphic study. J Neurosci 11: 563-583.
15. Heydorn A, Sondergaard BP, Ersboll B, Holst B, Nielsen FC, Haft CR et al. (2004). A library of 7TM receptor C-terminal tails. Interactions with the proposed post-endocytic sorting proteins ERM-binding phosphoprotein 50 (EBP50), N-ethylmaleimide-sensitive factor (NSF), sorting nexin 1 (SNX1), and G protein-coupled receptor-associated sorting protein (GASP). J Biol Chem 279: 54291-54303.
16. Hohmann AG, Tsou K, Walker JM (1998). Cannabinoid modula-tion of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2. Neurosci Lett 257: 119-122.
17. Hsieh C, Brown S, Derleth C, Mackie K (1999). Internalization and recycling of the CB1 cannabinoid receptor. J Neurochem 73: 493-501.
18. Iversen L (2003). Cannabis and the brain. Brain 126(Pt 6): 1252-1270.
19. Kalbasi Anaraki D, Sianati S, Sadeghi M, Ghasemi M, Javadi P, Ejtemaei Mehr S et al. (2008). Modulation by female sex hormones of the cannabinoid-induced catalepsy and analgesia in ovariectomized mice. Eur J Pharmacol 586: 189-196.
20. Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR (1988). Pharmacology and stereoselectivity of structurally novel canna-binoids in mice. J Pharmacol Exp Ther 247: 1046-1051.
21. Maldonado R (2002). Study of cannabinoid dependence in animals. Pharmacol Ther 95: 153-164.
22. Marsicano G, Lutz B (2006). Neuromodulatory functions of the endocannabinoid system. J Endocrinol Invest 29(3 Suppl): 27-46.
23. Martin BR, Sim-Selley LJ, Selley DE (2004). Signaling pathways involved in the development of cannabinoid tolerance. Trends Pharmacol Sci 25: 325-330.
24. Martini L, Waldhoer M, Pusch M, Kharazia V, Fong J, Lee JH et al. (2007). Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-asso-ciated sorting protein GASP1. FASEB J 21: 802-811.
25. Monory K, Blaudzun H, Massa F, Kaiser N, Lemberger T, Schutz G et al. (2007). Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice. PLoS Biol 5: e269.
26. Oviedo A, Glowa J, Herkenham M (1993). Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain Res 616: 293-302.
27. Patel S, Hillard CJ (2001). Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. J Pharmacol Exp Ther 297: 629-637.
28. Pertwee RG (2009). Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 156: 397-411.
29. Rawls SM, Cabassa J, Geller EB, Adler MW (2002). CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4- morpholinylmethyl)-1-(1-naphthalenyl-car-bonyl)-6H-pyrrolo[3,2,1ij] quinolin-6-one]-induced hypother-mia. J Pharmacol Exp Ther 301: 963-968.
30. Rinaldi-Carmona M, Pialot F, Congy C, Redon E, Barth F, Bachy A et al. (1996). Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain. Life Sci 58: 1239-1247.
31. Rodriguez de Fonseca F, Gorriti MA, Fernandez-Ruiz JJ, Palomo T, Ramos JA (1994). Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treat-ment. Pharmacol Biochem Behav 47: 33-40.
32. Romero J, Berrendero F, Garcia-Gil L, Lin SY, Makriyannis A, Ramos JA et al. (1999). Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide. Neurochem Int 34: 473-482. (Pubitemid 29243889)
33. Romero J, Garcia-Palomero E, Castro JG, Garcia-Gil L, Ramos JA, Fernandez-Ruiz JJ (1997). Effects of chronic exposure to delta- tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Brain Res Mol Brain Res 46: 100-108.
34. Rubino T, Forlani G, Vigano D, Zippel R, Parolaro D (2005). Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects. J Neurochem 93: 984-991.
35. Sim-Selley LJ (2003). Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Crit Rev Neurobiol 15: 91-119.
36. Sim-Selley LJ, Martin BR (2002). Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]-1,4-b enzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabi-noid receptor adaptation in mice. J Pharmacol Exp Ther 303: 36-44.
37. Sim-Selley LJ, Schechter NS, Rorrer WK, Dalton GD, Hernandez J, Martin BR et al. (2006). Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid adminis-tration. Mol Pharmacol 70: 986-996.
38. Sim LJ, Hampson RE, Deadwyler SA, Childers SR (1996). Effects of chronic treatment with delta9-tetrahydrocannabinol on canna-binoid-stimulated [35S]GTPgammaS autoradiography in rat brain. J Neurosci 16: 8057-8066.
39. Simonin F, Karcher P, Boeuf JJ, Matifas A, Kieffer BL (2004). Identification of a novel family of G protein-coupled receptor associated sorting proteins. J Neurochem 89: 766-775.
40. Spina E, Trovati A, Parolaro D, Giagnoni G (1998). A role of nitric oxide in WIN 55,212-2 tolerance in mice. Eur J Pharmacol 343: 157-163.
41. Tanowitz M, Von Zastrow M (2002). Ubiquitination-independent trafficking of G protein-coupled receptors to lysosomes. J Biol Chem 277: 50219-50222.
42. Tappe-Theodor A, Agarwal N, Katona I, Rubino T, Martini L, Swiercz J et al. (2007). A molecular basis of analgesic tolerance to cannabinoids. J Neurosci 27: 4165-4177.
43. Thompson D, Pusch M, Whistler JL (2007). Changes in G protein-coupled receptor sorting protein affinity regulate postendocytic targeting of G protein-coupled receptors. J Biol Chem 282: 29178-29185.
44. Wallace MJ, Newton PM, McMahon T, Connolly J, Huibers A, Whistler J et al. (2009). PKCepsilon regulates behavioral sensitivity, binding and tolerance to the CB1 receptor agonist WIN55,212-2. Neuropsychopharmacology 34: 1733-1742.
45. Whistler JL, Enquist J, Marley A, Fong J, Gladher F, Tsuruda P et al. (2002). Modulation of postendocytic sorting of G protein-coupled receptors. Science 297: 615-620.
46. Winter EE, Ponting CP (2005). Mammalian BEX, WEX and GASP genes: coding and non-coding chimaerism sustained by gene conversion events. BMC Evol Biol 5: 54.
47. Wu DF, Yang LQ, Goschke A, Stumm R, Brandenburg LO, Liang YJ et al. (2008). Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors. J Neurochem 104: 1132-1143.